Bin Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bin Huang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Baoli Hu
Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, USA
37 shared publications - Fan Lin
Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China
37 shared publications - Jie Li
Department of Bioinformatics, Nanjing Medical University, Nanjing, China
37 shared publications - Junxia Zhang
Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
37 shared publications - Kening Li
Department of Bioinformatics, Nanjing Medical University, Nanjing, China
37 shared publications - Liangyu Li
Department of Bioinformatics, Nanjing Medical University, Nanjing, China
37 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Information of TAMs harboring tumor-derived mutations
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Information of TAMs harboring tumor-derived mutations
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Gene signatures used for ssGSEA
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Gene signatures used for ssGSEA
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Macrophages phagocytose tumor cells.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Macrophages phagocytose tumor cells.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Clinical information of GBM patients included in this study
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Clinical information of GBM patients included in this study
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Tumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow–derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM.Significance:Bone marrow–derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Tumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow–derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM.Significance:Bone marrow–derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Figure from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Figure from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Data from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Supplementary Data from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma